HALO logo
halo search icon
CLN
Celon Pharma SA

CLN · Celon Pharma SA

20.65

PLN
-0.25 (-1.196%)
24/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

zl1.13B

PE

0.00

EV/EBITDA

108.3

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/07/2026 12:00:00 AM

Price Chart

Description

Celon Pharma SA is a pharmaceutical company, which engages in the research and manufacture of modern drugs. The firm's products include Aromek, Donepex, Ketrel, Salmex, and Valzek. It operates through the Generic Drug and Innovative segments. The Generic Drug segment pertains to the manufacture and sale of drugs registered and authorized for marketing. The Innovative segment involves activities that develop the documentation on the basis of which a drug could be registered or commercialized at the stage prior to drug registration. The company was founded by Maciej Wieczorek on June 20, 2002 and is headquartered in Lomianki, Poland.

  • All-Companies
  • All-Consensus
  • HALO 200
  • HALO All
  • HALO Earnings Momentum
  • HALO Growth
  • HALO Small
  • Recent Earnings upgrade

Key Fundamentals

EPS 3 yr Growth

94.00%

EBITDA Margin

-5.00%

Operating Cashflow

zł24m

Free Cash Flow Return

5.80%

ROIC

-19.20%

Interest Coverage

-6.60

Quick Ratio

1.20

Performance

52 weeks range

Low 18.5 - 24.2

Trade Value (12mth)

US$17,594.00

1 week

-0.48%

1 month

5.03%

YTD

2.45%

1 year

-12.55%

All time high

57.00

Additional Data

Shares Outstanding (Fully Diluted)

53m

HALO Sector

Healthcare

Next Company Report Date

28-Apr-27

Next Ex Dividend Date

27-Jun-24

Next Dividend Pay Date

04-Jul-24

Reporting Currency

PLN

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Celon Pharma SA (CLN:WAR)?
Halo FAQ
The current share price of Celon Pharma SA (CLN:WAR) is PLNzł20.65.
2
What is the 52-week high share price for Celon Pharma SA (CLN:WAR)?
Halo FAQ
The 52-week high share price for Celon Pharma SA (CLN:WAR) is PLNzł24.20.
3
What is the 52-week low share price for Celon Pharma SA (CLN:WAR)?
Halo FAQ
The 52-week low share price for Celon Pharma SA (CLN:WAR) is PLNzł18.50.
4
What is the dividend yield for Celon Pharma SA (CLN:WAR)?
Halo FAQ
Celon Pharma SA (CLN:WAR) does not pay a dividend.
5
What was Celon Pharma SA (CLN:WAR) last dividend payment?
Halo FAQ
The last dividend payment of Celon Pharma SA (CLN:WAR) is PLNzł0.08.
6
What is the franking level for Celon Pharma SA (CLN:WAR)?
Halo FAQ
Celon Pharma SA (CLN:WAR) has a franking level of 0.00%.
7
In which sector is Celon Pharma SA (CLN:WAR) classified?
Halo FAQ
Celon Pharma SA (CLN:WAR) is classified in the Healthcare.